Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
412 Results for "
HLA
" in MedChemExpress (MCE) Product Catalog:
Products (412)
412 Results for "HLA" in MCE Product Catalog:
15
15 Publications Verification
Cat. No.: HY-B1455
CAS No.: 18323-44-9
Target:
Clindamycin is an orally active and broad-spectrum bacteriostatic lincosamide antibiotic. Clindamycin can inhibit bacterial protein synthesis, possessing the ability to suppress the expression of virulence factors in Staphylococcus aureus at sub-inhibitory concentrations (sub-MICs). Clindamycin resistance results from enzymatic methylation of the antibiotic binding site in the 50S ribosomal subunit (23S rRNA). Clindamycin decreases the production of Panton-Valentine leucocidin (PVL), toxic-shock-staphylococcal toxin (TSST-1) or alpha-haemolysin (Hla). Clindamycin also can be used for researching malaria .
2
2 Cited Publications
Cat. No.: HY-161111
CAS No.: 3056394-59-0
Target:
Research Areas:
KVS0001 is a selective SMG1 inhibitor. KVS0001 elevates the expression of transcripts and proteins resulting from truncating mutations. KVS0001 increased the presentation of immune-targetable HLA class I-associated peptides from nonsense-mediated decay (NMD)-downregulated proteins on the surface of cancer cells. KVS0001 exerts anti-tumor properties and can be studied in research for NMD-related diseases, including cancer and inherited diseases .
1
1 Cited Publications
Cat. No.: HY-P85898
Synonyms: CD 74 antibody; CD74 antibody; CD74 antigen; invariant polypeptide of major histocompatibility complex; class II antigen-associated; antibody; CD74 antigen antibody; CD74 molecule antibody; CD74 molecule; major histocompatibility complex; class II invariant chain antibody; CLIP antibody; DHLAG antibody; Gamma chain of class II antigens antibody; HG2A_HUMAN antibody; HLA class II histocompatibility antigen gamma chain antibody; HLA DR antigens associated invariant chain antibody; HLA DR gamma antibody; HLA-DR antigens-associated invariant chain antibody; HLA-DR-gamma antibody; HLADG antibody; HLADR antigens associated invariant chain antibody; Ia antigen associated invariant chain antibody; Ia antigen-associated invariant chain antibody; Ia associated invariant chain antibody; Ia gamma antibody; Ii antibody; Invariant polypeptide of major histocompatibility complex class II antigen associated antibody; la-gamma antibody; Major histocompatibility complex class II invariant chain antibody; MHC HLA DR gamma chain antibody; MHC HLA-DR gamma chain antibody; p33 antibody; p35 antibody; Protein 41 antibody;
Cat. No.: HY-RS06217
Target:
Research Areas:
HLA-G Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-G gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P10662
CAS No.: 139143-28-5
Target:
Research Areas:
Cat. No.: HY-RS06196
Target:
Research Areas:
HLA-A Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS06197
Target:
Research Areas:
HLA-B Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS06198
Target:
Research Areas:
HLA-C Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS06199
Target:
Research Areas:
HLA-DMA Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-DMA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS06200
Target:
Research Areas:
HLA-DMB Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-DMB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS06201
Target:
Research Areas:
HLA-DOA Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-DOA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS06202
Target:
Research Areas:
HLA-DOB Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-DOB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS06210
Target:
Research Areas:
HLA-DRA Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-DRA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS06215
Target:
Research Areas:
HLA-E Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-E gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS06216
Target:
Research Areas:
HLA-F Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-F gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS06203
Target:
Research Areas:
HLA-DPA1 Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-DPA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS06204
Target:
Research Areas:
HLA-DPB1 Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-DPB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS06205
Target:
Research Areas:
HLA-DQA1 Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-DQA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS06206
Target:
Research Areas:
HLA-DQA2 Human Pre-designed siRNA Set A contains three designed siRNAs for HLA-DQA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
